Risk reduction of recurrent cardiovascular events in patients treated with the 20mg atorvastatin CNIC polypill compared to 3 active medication cohorts: a subanalysis of the NEPTUNO study

13 April 2023 (09:30 - 18:30)
Organised by:
Congress Presentation Part of: ePosters Secondary Prevention EAPC Premium Access ESC Preventive Cardiology 2023